Aespire Formulations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 11 Year, 29 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 M
as on 18-12-2024
- Revenue -8.47%
(FY 2022)
- Profit 204.32%
(FY 2022)
- Ebitda 467.22%
(FY 2022)
- Net Worth 17.37%
(FY 2022)
- Total Assets -8.54%
(FY 2022)
About Aespire Formulations
The Corporate was formerly known as Asmira Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.50 M.
Suman Sood, Rajat Sood, and Anupama Sarkar serve as directors at the Company.
- CIN/LLPIN
U74900DL2013PTC260979
- Company No.
260979
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Nov 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aespire Formulations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suman Sood  | Director | 26-Nov-2013 | Current |
| Rajat Sood | Director | 26-May-2016 | Current |
| Anupama Sarkar | Director | 26-Nov-2013 | Current |
Financial Performance of Aespire Formulations.
Aespire Formulations Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.47% decrease. The company also saw a substantial improvement in profitability, with a 204.32% increase in profit. The company's net worth Soared by an impressive increase of 17.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aespire Formulations?
In 2021, Aespire Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 May 2017 | ₹4.50 M | Open |
How Many Employees Work at Aespire Formulations?
Aespire Formulations has a workforce of 5 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aespire Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aespire Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
